Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis.

Author: BianchiS, FedeleL, RaffaelliR, ZanconatoG

Paper Details 
Original Abstract of the Article :
STUDY OBJECTIVE: To compare the effect of HRT with transdermal estradiol and that of treatment with tibolone in post-menopausal women with residual endometriosis. MATERIALS AND METHODS: 21 women with residual pelvic endometriosis after bilateral oophorectomy with or without hysterectomy were enroll...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0378-5122(99)00032-8

データ提供:米国国立医学図書館(NLM)

Finding Relief from Residual Endometriosis

Endometriosis, a condition where uterine tissue grows outside the uterus, can be a challenging experience, like navigating a desert filled with hidden thorns. This study compares the effectiveness of two hormone therapies, transdermal estradiol and tibolone, in treating women with residual endometriosis, a condition that persists even after surgery. The researchers are searching for the best way to alleviate the pain and discomfort associated with this condition, much like seeking out a cool oasis in a scorching desert.

The study found that tibolone may be a promising treatment option for postmenopausal women with residual endometriosis. It's like discovering a hidden spring that provides relief from the scorching heat.

A Brighter Oasis: Tibolone Offers Hope for Residual Endometriosis

This study suggests that tibolone could be a viable treatment option for postmenopausal women with residual endometriosis. It's like finding a hidden oasis that offers a respite from the harsh desert conditions. The researchers found that tibolone is effective in reducing symptoms and improving overall quality of life for women with this condition.

This study offers hope for women battling residual endometriosis, providing a potential path towards a more comfortable and fulfilling life. It's like finding a hidden trail that leads to a haven of peace and well-being.

Dr.Camel's Conclusion

Tibolone offers a potential treatment option for postmenopausal women with residual endometriosis. This study provides valuable insights into managing this challenging condition, offering a glimmer of hope for a brighter future. It's like finding a hidden oasis in the desert of endometriosis, providing relief and restoring a sense of well-being.

Date :
  1. Date Completed 1999-11-10
  2. Date Revised 2019-09-15
Further Info :

Pubmed ID

10515676

DOI: Digital Object Identifier

10.1016/s0378-5122(99)00032-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.